Characteristic | N (%) |
---|---|
Age (years) | Â |
Median (range) | 55.3 (32 − 80) |
<55 | 79 (46.2) |
≥55 | 92 (54.1) |
FIGO stage | Â |
I | 111 (64.9) |
II | 25 (14.6) |
III | 31 (18.1) |
IV | 4 (2.3) |
Surgical procedures | Â |
TAH + BSO + OM | 142 (83.0) |
BSO + OM | 6 (3.5) |
USO + OM | 8 (4.7) |
OM | 15 (8.8) |
Surgical status | Â |
Complete resection | 146 (85.4) |
Incomplete resection | 25 (14.6) |
Adjuvant chemotherapy | Â |
Yes | 129 (75.4) |
Paclitaxel + Carboplatin | 77 |
Docetaxel + Carboplatin | 35 |
Irinotecan + Cisplatin | 12 |
Gemcitabine + Carboplatin | 1 |
Not available | 4 |
No | 42 (24.6) |
Recurrence | Â |
Yes | 44 (25.7) |
No | 127 (74.3) |
Death | Â |
Yes | 32 (18.7) |
No | 139 (81.3) |